Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Left atrial (LA) dissection is a rare, but potentially serious, complication that most commonly arises following mitral valve surgery.

Case Summary: In this report, the authors describe an unusual case of a patient presenting with chest pain and presyncopal symptoms after cardiac surgery who ultimately received a diagnosis of LA dissection and associated complete heart block. Although permanent pacemaker placement was required as a result of recurrent episodes of complete heart block, the patient was otherwise managed safely using a conservative approach without surgical reintervention.

Discussion: LA dissection is a surgical complication most commonly identified following mitral valve intervention, and it may be associated with debridement of calcium along the mitral annulus. Urgent surgical repair is indicated when LA dissection results in hemodynamic instability, typically through obstruction of the left atrial outflow, obstruction of the left atrial inflow, or cardiac tamponade. Although complete heart block is not a previously reported downstream complication of LA dissection, aspects of the atrioventricular (AV) node, particularly the compact AV node, lie within the interatrial septum and could be damaged by dissection.

Take-home Messages: LA dissection is a rare, but potentially serious, complication that most commonly arises following mitral valve surgery. Although the presence of hemodynamic instability renders LA dissection a surgical emergency, a conservative approach that avoids reintervention may otherwise be considered.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12235145PMC
http://dx.doi.org/10.1016/j.jaccas.2025.103557DOI Listing

Publication Analysis

Top Keywords

left atrial
16
complete heart
16
heart block
16
complication commonly
12
mitral valve
12
dissection
8
atrial dissection
8
dissection associated
8
associated complete
8
cardiac surgery
8

Similar Publications

Aims: The PARACHUTE-HF trial (NCT04023227) is evaluating the effect of sacubitril/valsartan compared with enalapril on a hierarchical composite of cardiovascular events (cardiovascular death, first heart failure hospitalization), and change in N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in participants with heart failure and reduced ejection fraction (HFrEF) caused by chronic Chagas cardiomyopathy (CCC). We describe the baseline characteristics of participants in PARACHUTE-HF compared with prior HFrEF trials.

Methods And Results: PARACHUTE-HF, a multicentre, active-controlled, open-label trial, enrolled 922 participants with confirmed CCC, New York Heart Association (NYHA) functional class II-IV, and left ventricular ejection fraction (LVEF) ≤40%.

View Article and Find Full Text PDF

Introduction: Repaired total anomalous pulmonary venous connection (TAPVC) patients with preoperative pulmonary venous obstruction (PVO) have reductions in echocardiographic metrics, such as left atrial reservoir function and pulmonary venous variability index (PVVI). We hypothesized reduced preoperative left atrial strain mechanics in isolated TAPVC patients serve as risk factors for postoperative PVO. We also evaluated echocardiographic metrics and clinical characteristics associated with preoperative and postoperative PVO, as well as compared these to healthy controls.

View Article and Find Full Text PDF

Background: Ischemia with non-obstructive coronary arteries (INOCA) represents a diagnostic and therapeutic challenge, often related to coronary microvascular dysfunction (CMD). Identifying non-invasive electrocardiographic markers that predict ischemia in this population remains a clinical priority. P-wave peak time (PWPT), reflecting atrial conduction delay, has been linked to ischemic pathophysiology.

View Article and Find Full Text PDF

Background: Peripartum cardiomyopathy (PPCM) is a rare, life-threatening form of heart failure occurring in late pregnancy or postpartum, with variable clinical course and outcomes. We report preliminary clinical and echocardiographic findings from a national Italian registry of PPCM patients METHODS: The study was approved by the institutional Ethics Committee and registered at ClinicalTrials.gov (NCT05878041).

View Article and Find Full Text PDF